Visudyne Manufacturer QLT Must Pay Sales Royalties To AMD Therapy Patent Inventors
This article was originally published in The Pink Sheet Daily
Executive Summary
Court must still decide whether Massachusetts Ear and Eye Infirmary, which won the patent case, is entitled to payments on past sales of the Novartis-marketed eye treatment.